Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: A systematic review.

[1]  S. Sivarajan,et al.  Lactate Dehydrogenase - A Biochemical Marker for the Prediction of Adverse Outcomes in Pre-Eclampsia , 2020, Journal of Evolution of Medical and Dental Sciences.

[2]  M. Upadya,et al.  Hypertensive disorders in pregnancy , 2018, Indian journal of anaesthesia.

[3]  K. Khan,et al.  Development and validation of prediction models for risk of adverse outcomes in women with early-onset pre-eclampsia: protocol of the prospective cohort PREP study , 2017, Diagnostic and Prognostic Research.

[4]  L. Magee,et al.  Preventing deaths due to the hypertensive disorders of pregnancy , 2016, Best practice & research. Clinical obstetrics & gynaecology.

[5]  S. Agrawal,et al.  Prediction of Adverse Maternal Outcomes in Preeclampsia Using a Risk Prediction Model , 2016, The Journal of Obstetrics and Gynecology of India.

[6]  Z. Al-Rubaie,et al.  The performance of risk prediction models for pre‐eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review , 2016, BJOG : an international journal of obstetrics and gynaecology.

[7]  E. Steegers,et al.  The sFlt-1/PlGF ratio associates with prolongation and adverse outcome of pregnancy in women with (suspected) preeclampsia: analysis of a high-risk cohort. , 2016, European journal of obstetrics, gynecology, and reproductive biology.

[8]  M. Ergin,et al.  Increased levels of serum clusterin is associated with intrauterine growth restriction and adverse pregnancy outcomes in preeclampsia , 2016, Journal of perinatal medicine.

[9]  F. Yassaee.  Hyperuricemia and Perinatal Outcomes in Patients with Severe Preeclampsia , 2015 .

[10]  A. Tokmak,et al.  May maternal anti-mullerian hormone levels predict adverse maternal and perinatal outcomes in preeclampsia? , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[11]  L. Magee,et al.  The hypertensive disorders of pregnancy (29.3). , 2015, Best practice & research. Clinical obstetrics & gynaecology.

[12]  J. Haddow,et al.  Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia , 2015, Prenatal diagnosis.

[13]  F. Prefumo,et al.  The prognostic role of various indices and ratios of Doppler velocimetry in patients with pre-eclampsia , 2015, Clinical and experimental hypertension.

[14]  L. Magee,et al.  Hypertensive Disorders of Pregnancy: A Systematic Review of International Clinical Practice Guidelines , 2014, PloS one.

[15]  L. Magee,et al.  Uric Acid as a predictor of adverse maternal and perinatal outcomes in women hospitalized with preeclampsia. , 2014, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[16]  L. Magee,et al.  Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[17]  L. Magee,et al.  Pre-eclampsia: An Update , 2014, Current Hypertension Reports.

[18]  R. Morris,et al.  PMM.43 The Predictive Value of Urinary Albumin: Creatinine Ratio In Pregnancy , 2014, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[19]  J. Biggio,et al.  Risk of Adverse Pregnancy Outcomes in Women With Mild Chronic Hypertension Before 20 Weeks of Gestation , 2014, Obstetrics and gynecology.

[20]  S. Barat,et al.  Does proteinura in preeclampsia have enough value to predict pregnancy outcome? , 2014, Clinical and experimental obstetrics & gynecology.

[21]  L. Magee,et al.  The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. , 2014, Pregnancy hypertension.

[22]  João Paulo Souza,et al.  Risk Factors of Pre-Eclampsia/Eclampsia and Its Adverse Outcomes in Low- and Middle-Income Countries: A WHO Secondary Analysis , 2014, PloS one.

[23]  Jing Li,et al.  A Risk Prediction Model for the Assessment and Triage of Women with Hypertensive Disorders of Pregnancy in Low-Resourced Settings: The miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Multi-country Prospective Cohort Study , 2014, PLoS medicine.

[24]  J. V. van Roosmalen,et al.  Pre-Eclampsia Increases the Risk of Postpartum Haemorrhage: A Nationwide Cohort Study in The Netherlands , 2013, PloS one.

[25]  E. Gratacós,et al.  Prognostic Role of Maternal Neutrophil Gelatinase-Associated Lipocalin in Women with Severe Early-Onset Preeclampsia , 2013, Fetal Diagnosis and Therapy.

[26]  James M. Roberts,et al.  Hypertension in Pregnancy: Executive Summary , 2013 .

[27]  L. Poston,et al.  Association of Proteinuria Threshold in Pre-Eclampsia with Maternal and Perinatal Outcomes: A Nested Case Control Cohort of High Risk Women , 2013, PloS one.

[28]  H. Korkes,et al.  sFlt-1/PlGF ratio as a prognostic marker of adverse outcomes in women with early-onset preeclampsia. , 2013, Pregnancy hypertension.

[29]  A. Leaños-Miranda,et al.  Circulating Angiogenic Factors and Urinary Prolactin as Predictors of Adverse Outcomes in Women With Preeclampsia , 2013, Hypertension.

[30]  C. Bombardier,et al.  Assessing Bias in Studies of Prognostic Factors , 2013, Annals of Internal Medicine.

[31]  J. Guibourdenche,et al.  Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction , 2012, PloS one.

[32]  H. Soydinç,et al.  Risk factors for maternal mortality in eclampsia: analysis of 167 eclamptic cases. , 2012, European review for medical and pharmacological sciences.

[33]  S. Maynard,et al.  Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[34]  R. Riley,et al.  Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.

[35]  S. Salahuddin,et al.  PP059. Angiogenic factors and risk of preeclampsia related adverse outcomes in twin pregnancies. , 2012, Pregnancy hypertension.

[36]  S. Ghosh,et al.  Association between placental growth factor levels in early onset preeclampsia with the occurrence of postpartum hemorrhage: A prospective cohort study. , 2012, Pregnancy hypertension.

[37]  K. Lim,et al.  Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia , 2012, Circulation.

[38]  J. Hutcheon,et al.  Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[39]  J. Hutcheon,et al.  The role of platelet counts in the assessment of inpatient women with preeclampsia. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[40]  J. Hutcheon,et al.  Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[41]  J. Aarnoudse,et al.  Prediction of progression to a high risk situation in women with gestational hypertension or mild pre‐eclampsia at term , 2011, The Australian & New Zealand journal of obstetrics & gynaecology.

[42]  Ziguang Qu,et al.  Oxygen saturation as a predictor of adverse maternal outcomes in women with preeclampsia. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[43]  K. Khan,et al.  How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta‐analysis , 2011, Acta obstetricia et gynecologica Scandinavica.

[44]  J. Zamora,et al.  Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review , 2011, Acta obstetricia et gynecologica Scandinavica.

[45]  Z. Bhutta,et al.  PIERS proteinuria: relationship with adverse maternal and perinatal outcome. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[46]  S. Ozkan,et al.  An analysis of HELLP syndrome cases: does platelet count predict adverse maternal and fetal outcomes in women with HELLP syndrome? , 2011, Archives of Gynecology and Obstetrics.

[47]  Nuzhat Aziz,et al.  Clinical symptoms and laboratory parameters do not predict adverse maternal and fetal outcomes in HELLP. , 2011, Pregnancy hypertension.

[48]  J. Hutcheon,et al.  Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model , 2011, The Lancet.

[49]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[50]  J. Moodley,et al.  Comparison of pregnancy outcomes in women with hypertensive disorders of pregnancy using 24‐hour urinary protein and urinary microalbumin to creatinine ratio , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[51]  B. Mol,et al.  Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis. , 2009, European journal of obstetrics, gynecology, and reproductive biology.

[52]  T. Alonzo.  Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating By Ewout W. Steyerberg , 2009 .

[53]  L. Magee,et al.  Predicting adverse outcomes in women with severe pre-eclampsia. , 2009, Seminars in perinatology.

[54]  A. Coomarasamy,et al.  Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review , 2009, BMC medicine.

[55]  J. C. Houwelingen,et al.  Bivariate Random Effects Meta-Analysis of ROC Curves , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

[56]  M. Martel.  Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. , 2008, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[57]  Y. MacNab,et al.  Current CHS and NHBPEP Criteria for Severe Preeclampsia Do Not Uniformly Predict Adverse Maternal or Perinatal Outcomes , 2007, Hypertension in pregnancy.

[58]  A. Coomarasamy,et al.  Accuracy of serum uric acid in predicting complications of pre‐eclampsia: a systematic review , 2006, BJOG : an international journal of obstetrics and gynaecology.

[59]  J. Simpson,et al.  Proteinuria in pre‐eclampsia: how much matters? , 2005, BJOG : an international journal of obstetrics and gynaecology.

[60]  D. Altman,et al.  Diagnostic tests 4: likelihood ratios , 2004, BMJ : British Medical Journal.

[61]  F. B. Salem,et al.  Facteurs de risque d’éclampsie : étude cas-témoins , 2003 .

[62]  D. Grové,et al.  Urinary protein excretion and expectant management of early onset, severe pre‐eclampsia , 2002, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[63]  H. Honest,et al.  Reporting of measures of accuracy in systematic reviews of diagnostic literature , 2002, BMC health services research.

[64]  G. Saade,et al.  Risk factors for abruptio placentae and eclampsia: analysis of 445 consecutively managed women with severe preeclampsia and eclampsia. , 1999, American journal of obstetrics and gynecology.

[65]  J. Girling,et al.  Liver function tests in pre‐eclampsia: importance of comparison with a reference range derived for normal pregnancy , 1997, British journal of obstetrics and gynaecology.

[66]  B. Sibai,et al.  The importance of urinary protein excretion during conservative management of severe preeclampsia. , 1996, American journal of obstetrics and gynecology.

[67]  L E Moses,et al.  Estimating Diagnostic Accuracy from Multiple Conflicting Reports , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[68]  J. Hobbins,et al.  Clinical Significance of Liver Dysfunction in Pregnancy-Induced Hypertension1 , 1988, American journal of perinatology.

[69]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[70]  G. Saade,et al.  472: External validation of the fullPIERS (Preeclampsia Integrated Estimate of RiSk) model , 2016 .

[71]  A. Tita,et al.  445: Predicting adverse pregnancy outcomes associated with chronic hypertension: a classification and regression tree (CART) Analysis , 2016 .

[72]  G. Dumont,et al.  Assessing the incremental value of blood oxygen saturation (SpO(2)) in the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model. , 2015, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[73]  U. Ukah.  [247-POS]: Preliminary external validation of the fullPIERS risk prediction model for women with pre-eclampsia using the miniPIERS dataset. , 2015 .

[74]  S. Tumanyan,et al.  [Predictors of renal dysfunction and its correction in women with preeclampsia and alimentary obesity]. , 2015, Anesteziologiia i reanimatologiia.

[75]  S. Boccia,et al.  Pregnancy Hypertension : An International Journal of Women ’ s Cardiovascular Health , 2015 .

[76]  U. V. Ukah,et al.  The Risks of adverse outcomes (maternal and foetal) in hypertensive disorders of pregnancy , 2014 .

[77]  SN Lumbanraja.  DETERMINING THE MATERNAL CHARACTERISTICS THAT PREDICTS THE ADVERSE OUTCOMES FOR PATIENTS WITH PREECLAMPSIA , 2014 .

[78]  Sofia Dias,et al.  BJOG: An International Journal of Obstetrics & Gynaecology , 2013 .

[79]  E. Schisterman,et al.  Pregnancy outcomes in smokers who develop pre-eclampsia. , 2005, Paediatric and perinatal epidemiology.

[80]  K. Ben Salem,et al.  [Risk factors for eclampsia: a case-control study]. , 2003, Annales francaises d'anesthesie et de reanimation.

[81]  G. Propper.  Chest pain. , 1997, Pediatric nursing.

[82]  Henry Southern,et al.  The retrospective review , 1820 .

[83]  Inmaculada Arostegui,et al.  The IRYSS-COPD appropriateness study: objectives, methodology, and description of the prospective cohort , 2011, BMC health services research.